Item 5. Market for Registrant’s Common Equity
ITEM
5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market
Information
We
have our common stock listed on The Nasdaq Capital Market under the symbol “INHD”.
Holders
As
of December 6, 2024, there were approximately 25 stockholders of record of our common stock. The actual number of stockholders is greater
than this number of record holders, and includes stockholders who are beneficial owners, but whose shares are held in street name by
brokers and other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust by
other entities.
Reverse
Stock Split
On
November 30, 2022, the Company effected a forward stock split (the “Stock Split”) of the Company’s issued and outstanding
shares of the common stock at a split ratio of 2-for-1. Further on July 24, 2023, the Company effected a reverse stock split (the “Reverse
Stock Split”) of the Company’s issued and outstanding shares of the common stock at a split ratio of 1-for-2 such that every
holder of common stock of the Company shall receive one share of common stock for every two shares of common stock held and to reduce
the number of authorized shares of common stock from 200,000,000 to 100,000,000. Shortly after the Reverse Stock Split, the Board of
Directors of the Company approved issuance of additional shares to preserve the original purchase price per share of the shares sold
in the period from February 1 to June 30, 2023.
On
October 9, 2024, the Company completed a 1-for-10 reverse stock split of its issued and outstanding common stock, no par value, (the
“Reverse Stock Split”). As a result of the Reverse Stock Split, each share of common stock issued and outstanding immediately
prior to October 9, 2024 were automatically converted into one-tenth (1/10) of a share of common stock. The Common Stock began trading
on a Reverse Stock Split-adjusted basis on the Nasdaq Capital Market on October 10, 2024. The trading symbols for the Common Stock remains
“INHD”. The Reverse Stock Split did not reduce the number of authorized shares of Common Stock and did not change the par
value of the Common Stock. The Reverse Stock Split affected all stockholders uniformly. Except to the extent that the Reverse Stock Split
resulted in the stockholders’ fractional shares being rounded up, no other effects affect stockholder’s ownership percentage
of the Company’s shares of Common Stock. 199,787 fractional shares were issued in connection with the Reverse Stock Split.
All
common share and per-share amounts in this Form 10-K have been retroactively restated to reflect the effect of the Reverse Stock Split.
17
Dividend
Policy
We
have not declared any cash dividends since inception, and we do not anticipate paying any dividends in the foreseeable future. Instead,
we anticipate that all of our earnings will be used to provide working capital, to support our operations, and to finance the growth
and development of our business. The payment of dividends is within the discretion of the Board and will depend on our earnings; capital
requirements; financial condition; prospects; applicable Texas law, which provides that dividends are only payable out of surplus or
current net profits; and other factors our Board might deem relevant. There are no restrictions that currently limit our ability to pay
dividends on our common stock other than those generally imposed by applicable state law.
Transfer
Agent
VStock
Transfer, LLC., 18 Lafayette Place, Woodmere, New York 11598.
Recent
Sales of Unregistered Securities
During
the period from October 1, 2022 to September 30, 2024, we have granted or issued the following securities that were not registered under
the Securities Act:
(a)
Issuance
of common stock.
●
On
December 3, 2022, the Company issued 14,286 shares of its common stock to an accredited investor at $35 per share for $500,000 in
cash.
●
On
March 13, 2023, the Company issued 2,703 shares of its common stock to an accredited investor at $37 per share for $100,000 in cash.
●
On
April 25, 2023, The Company issued 7,895 shares of its common stock to an accredited investor at $38 per share for $300,000 in cash.
●
On
June 20, 2023, the Company issued 1,316 shares of its common stock for a total value of $50,000 for services to be rendered during
next twelve months by the immediate relative of the Company’s Chief Financial Officer.
●
On
June 20, 2023, the Company issued 1,974 shares of its common stock for a total value of $75,000 for services to be rendered during
next twelve months by one nonemployee contractor. These shares were valued at $38 per share.
●
On
July 24, 2023, the Company issued 1,352 shares of its common stock to an accredited investor for no additional consideration following
the Company’s previously disclosed reverse stock split in July 2023.
●
On
July 24, 2023, the Company issued 3,947 shares of its common stock to an accredited investor for no additional consideration following
the Company’s previously disclosed reverse stock split in July 2023.
●
On
July 24, 2023, the Company issued 658 shares of its common stock to an accredited investor for no additional consideration following
the Company’s previously disclosed reverse stock split in July 2023.
●
On
July 24, 2023, the Company issued 987 shares of its common stock to an accredited investor for no additional consideration following
the Company’s previously disclosed reverse stock split in July 2023.
●
On
July 24, 2023, the Company issued 7,143 shares of its common stock to an accredited investor for no additional consideration following
the Company’s previously disclosed reverse stock split in July 2023.
●
On
January 1, 2024, the Company granted 5,000 shares to one advisory firm for a total value of $72,000 for advisory services to be rendered
during next twelve months. The advisory firm helps and supports the Company in the capital market, including developing capital market
strategies, sourcing different providers including investment banks and underwriters, etc. These shares were issued by the transfer agent
on July 15,2024 and valued at $14 per share.
18
The
issuance of the common stock in private placements was deemed exempt from registration under Section 4(a)(2) of the Securities Act or
Regulation D promulgated thereunder in that the issuance of securities were made to an accredited investor and did not involve a public
offering. The recipient of such securities represented its intention to acquire the securities for investment purposes only and not with
a view to or for sale in connection with any distribution thereof.
(b)
Warrants.
●
On
December 18, 2023, the Company issued warrants to AC Sunshine Securities LLC, the underwriter of its IPO (as defined below), to purchase
up to 20,125 shares of common stock at an exercise price of $48 per share.
Use
of Proceeds from our Initial Public Offering of Common Stock
On
December 18, 2023, we closed our initial public offering (the “IPO”), in which we sold and issued 250,000 shares of our common
stock at a price to the public of $40 per share. We received approximately $7,859,533 in aggregate net proceeds from our IPO after deducting
underwriting discounts and commissions and other offering expenses. AC Sunshine Securities LLC was the underwriter of our IPO.
The
offer and sale of all of the shares of our common stock in our IPO were registered under the Securities Act pursuant to a registration
statement on Form S-1 (File No. 333-273429), which was declared effective by the SEC on November 9, 2023.
As
of January 11, 2023, we have used approximately $0.9 million of the net proceeds from our IPO for working capital and general corporate
purposes. There has been no material change in our planned use of the net proceeds from our IPO as described in our final prospectus
filed pursuant to Rule 424(b)(4) under the Securities Act with the SEC on December 4, 2023.
Purchases
of Equity Securities
Neither
we nor any “affiliated purchaser,” as defined in Rule 10b-18(a)(3) of the Exchange Act, purchased any of our equity securities
during the period covered by this annual report.
Securities
Authorized for Issuance Under Equity Compensation Plans.
The
information required by this Item regarding equity compensation plans is incorporated by reference to the information set forth in Item
12 of this Annual Report on Form 10-K.
ITEM
6. [RESERVED]
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.